Vimarsana
Biggest News Aggregation in the World

Page 8 - Deepak Talwar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deepak Talwar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deepak Talwar Today - Breaking & Trending Today

Ongoing immigration delays leave more than a million waiting to become citizens and permanent residents - Vimarsana News

Ongoing immigration delays leave more than a million waiting to become citizens and permanent residents

Canada had a backlog of more than 1.8 million immigration applications as of Feb. 1, including 519,030 permanent residence and 448,000 Canadian citizenship applications, according to IRCC data. Some have been waiting for four years to get their citizenship.

Source: cbc.ca
Here's how Vitamin C helps boost immunity against non-communicable diseases - Vimarsana News

Here's how Vitamin C helps boost immunity against non-communicable diseases

With an accelerated rise in the prevalence of non-communicable diseases (NCD) in India, Vitamin C has become one of the most needed nutrients to lead a healthy life.

Ongoing immigration delays leave nearly a million waiting to become citizens and permanent residents - Vimarsana News

Ongoing immigration delays leave nearly a million waiting to become citizens and permanent residents

Canada had a backlog of more than 1.8 million immigration applications as of Feb. 1, including 519,030 permanent residence and 448,000 Canadian citizenship applications, according to IRCC data. Some have been waiting for four years to get their citizenship.

Source: cbc.ca
Ongoing immigration delays leave more than a million waiting to become citizens and permanent residents - Vimarsana News

Ongoing immigration delays leave more than a million waiting to become citizens and permanent residents

In total, more than 1.8 million immigration applications are waiting to be processed

Drug war intensifies for COVID-19 - Vimarsana News

Drug war intensifies for COVID-19

The pandemic has entered yet another phase, with the Omicron variant wreaking havoc across the globe. The high infection rate of this new cause for concern, in India, has also triggered a ‘war of medical opinions’ between the Indian Council of Medical Research (ICMR) and the Drugs Controller General of India (DCGI). Pharma majors are churning out viable treatment options at a feverish pace, in a bid to become the most widely accepted drug listed in COVID-19 treatment protocols. Merck’s Molnupiravir is one such drug that is embroiled in a ‘safety vs efficacy’ contest. Let’s investig...